668|1258|Public
2500|$|In March 2010 Health Canada {{advised the}} public that illegal [...] "Herbal Diet Natural" [...] had been found on the market, {{containing}} sibutramine, which is a prescription drug in Canada, without listing sibutramine as an ingredient. In October 2010 FDA notified consumers that [...] "Slimming Beauty Bitter Orange Slimming Capsules contain the <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> sibutramine, a prescription-only drug which is a stimulant. Sibutramine is not listed on the product label." ...|$|E
50|$|Title III {{directs the}} FDA {{to assess and}} collect fees related to generic drugs: (1) a {{one-time}} backlog fee for abbreviated new drug applications pending on October 1, 2012; (2) a drug master file fee; (3) an abbreviated new drug application and prior approval supplement filing fee, {{as well as an}} additional fee for certain <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> information; and (4) a generic drug facility fee and <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> facility fee.|$|E
5000|$|Mylan Laboratories Limited - {{headquartered}} in Hyderabad, India; operates nine <b>Active</b> <b>pharmaceutical</b> <b>ingredient</b> (API) and intermediate manufacturing facilities located in India and China ...|$|E
50|$|Then in June 2015 the FDA {{issued an}} Import alert {{including}} SIMS. This alert stated that some <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> {{appeared to be}} misbranded. Therefore, any <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> can be refused admission if the facility they are from is listed in this alert.|$|R
50|$|Designing {{integrated}} continuous manufacturing {{strategies for}} preparing <b>active</b> <b>pharmaceutical</b> <b>ingredients.</b> Within a broader context, I also {{been involved in}} developing end-to-end manufacturing processes which handle a variety of intermediate reactions, separations, crystallizations as well as drying and formulation to generate <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> in one controlled process.|$|R
50|$|In 1960, Taro begins {{production}} of <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> (APIs).|$|R
5000|$|When {{describing}} the pharmacokinetic {{properties of the}} chemical that is the active ingredient or <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> (API), pharmacologists are often interested in L-ADME: ...|$|E
50|$|Due to the hyperproliferative {{action against}} {{epidermal}} cells, S1P {{has been considered}} as an <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> for hyperproliferative skin diseases, in particular, psoriasis vulgaris and acne vulgaris.|$|E
5000|$|Fluctuations in dosage of the <b>Active</b> <b>Pharmaceutical</b> <b>Ingredient,</b> {{caused by}} uneven {{distribution}} of the API in the tableting blend (either due to poor mixing or separation in process).|$|E
5000|$|The {{company makes}} <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> at three sites in India: ...|$|R
5000|$|CGMP charges {{involving}} <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> {{and other}} drug component manufacturing deficiencies; ...|$|R
5000|$|... the {{pharmaceuticals}} division which manufactures Penicillin-G Potassium (fermentation-based), and <b>active</b> <b>pharmaceutical</b> <b>ingredients,</b> ...|$|R
50|$|Amylmetacresol (AMC) is an {{antiseptic}} used {{to treat}} infections of the mouth and throat. It is used as an <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> in Strepsils, CÄ“pacol, Gorpils and Lorsept throat lozenges.|$|E
50|$|CSPC {{produces}} both <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> (API) and formulations. API products includepenicillin, cefalosporins, synthetic vitamins, {{caffeine and}} ranitidine. Formulations include antibiotics, butylphthalide (NBP) and analgesics, {{in addition to}} nearly 1,000 other products.|$|E
5000|$|Lu, J.; Yi-Ping Li, Y-P; Wang, J.; Li, Z.; Rohani, S. and C-B Ching, Crystallization of an <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> that oils out. Separation and Purification Technology, (96), 1-6 (2012). (impact factor=2.921).|$|E
5000|$|Amino acids, {{nucleic acids}} and related compounds, health care {{products}} and other <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> ...|$|R
5000|$|Novacap : (50.1% investment), {{international}} group that produces and distributes <b>Active</b> <b>Pharmaceutical</b> <b>Ingredients</b> (APIs) and essential chemicals products.|$|R
50|$|Cambrex Corporation {{is a life}} {{sciences}} company that provides products and services for small molecule <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> (APIs).|$|R
50|$|As an O/W emulsion, MLE can be {{also used}} as a vehicle (carrier) for topical drugs. The {{multiple}} layer of MLE offers stabilization of <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> (API) and efficient penetration of API into skin.|$|E
50|$|The {{extinction}} coefficient of CAP changes during its forced degradation by heat, {{a fact that}} will have to be accounted for in pharmaceutical stability studies should it be manufactured as a microbicide <b>active</b> <b>pharmaceutical</b> <b>ingredient.</b>|$|E
5000|$|Biocon and Optimer Pharmaceuticals, a {{biopharmaceutical}} company {{focused on}} the treatment of serious infections such as Clostridium Difficile Infection (CDI), have entered into a long-term supply agreement for the commercial manufacturing of the <b>active</b> <b>pharmaceutical</b> <b>ingredient,</b> fidaxomicin., ...|$|E
5000|$|Lu, J. and S. Rohani, Polymorphism and Crystallization of <b>Active</b> <b>Pharmaceutical</b> <b>Ingredients</b> (APIs), Current Medicinal Chemistry, 16, 884-905 (2009).|$|R
5000|$|Phyton Biotech uses {{plant cell}} culture systems to {{manufacture}} <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> based on taxanes, including paclitaxel and docetaxel ...|$|R
50|$|Manufacturers of <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> {{that go into}} {{medication}} {{have lost}} Rs.500 crore till 26 September because of the strike.|$|R
50|$|Eli Lilly and Company is {{responsible}} for the manufacture and supply of Erbitux in bulk-form <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> (API) for clinical and commercial use in the U.S. and Canada, and Bristol-Myers Squibb purchases the API for commercial use from Eli Lilly.|$|E
50|$|The most famed {{product of}} Weesp is Van Houten chocolate. Before cocoa {{production}}, {{the local economy}} had been based on beer breweries, jenever distilleries, production of Weesper porselein, and trade, due to its location on a branch point of waterways. In the 21st century, the economy is very diverse. There were large facilities of Solvay Pharmaceuticals, until February 2010 when Abbott Laboratories of North Chicago, IL, USA acquired Solvay Pharmaceuticals. At this site there is a chemical plant which manufactures <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> for Abbott brands Duphalac and Duphaston and a biologic plant which manufactures <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> for Abbott's flu vaccine Influvac. The local specialty is the Weesper Mop cookie, {{which is based on}} mashed almond.|$|E
50|$|Akbarieh {{provides}} {{a wide spectrum}} of API (<b>Active</b> <b>Pharmaceutical</b> <b>Ingredient),</b> animal health and nutrition products, cosmetic raw materials and finished goods, and food additives. The Company is the largest supplier of vitamins for the manufacturing of human and animal drugs and nutrition needs.|$|E
50|$|Shanghai, China: Dishman Pharmaceuticals and Chemicals (Shanghai) Co., Ltd. The site {{manufactures}} intermediates and <b>active</b> <b>pharmaceutical</b> <b>ingredients,</b> including highly potent drugs.|$|R
50|$|RPG Life Sciences (RPGLS) is an Indian {{pharmaceutical}} company, {{formerly known}} as Searle (India) Ltd. Its three major sources of business are manufacturing and marketing of bulk drugs, also known as API, (<b>Active</b> <b>Pharmaceutical</b> <b>Ingredients),</b> <b>pharmaceutical</b> formulation and fermentation & biotechnology.|$|R
5000|$|Create {{innovative}} {{engineering tools}} needed to develop, design and scale up cost novel effective processes for the manufacturing of <b>active</b> <b>pharmaceutical</b> <b>ingredients</b> (API); ...|$|R
50|$|Amendments to the August 2011 Act on the Scope of Healthcare Provision and the 1 October 2011 Act on Drugs and Medical Aids {{introduce}} an <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> (API) prescription, stipulating {{that doctors}} in Slovakia should prescribe only the API {{instead of a}} specific drug brand.|$|E
50|$|A {{filter dryer}} {{is a piece}} of process {{equipment}} used during the filtration and drying phase of a pharmaceutical, bio pharmaceutical or chemical process for an <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> (API) or other compounds production.Filter Dryers are designed for washing and isolating solids with or without integrated containment systems.|$|E
5000|$|Hebei Yuxing Bio-Engineering Co. Ltd is a Chinese <b>active</b> <b>pharmaceutical</b> <b>ingredient</b> (API) {{company that}} {{exports to the}} United States of America. Recently, the US FDA issued a warning letter due to [...] "evidence {{that the company was}} keeping {{incomplete}} documentation and did not adequately investigate instances of microbial contamination." ...|$|E
5000|$|CBL Patras, {{a global}} {{manufacturer}} of specialty chemicals and <b>active</b> <b>pharmaceutical</b> <b>ingredients,</b> is a startup from {{a professor of}} the University of Patras ...|$|R
5000|$|... 2004 - Ultrafine (a {{supplier}} of contract manufacturing services for drug development), Tetrionics (a producer of high potency and cytotoxic <b>active</b> <b>pharmaceutical</b> <b>ingredients)</b> ...|$|R
5000|$|Naari {{develops}} and manufactures a large {{range of}} women health care products including <b>Active</b> <b>pharmaceutical</b> <b>ingredients</b> (APIs), Formulations, Diagnostics. The products of Naari include: ...|$|R
